Bonesupport
-
Financial
Bonesupport closes $57m IPO
JUNE 29, 2017 BY FINK DENSFORD BoneSupport said last week it closed its initial public offering, raising a total of…
Read More » -
Biologics
Nasdaq Stockholm Welcomes Bonesupport to the Main Market
Stockholm, June 21, 2017 — Nasdaq (Nasdaq: NDAQ) announced that Bonesupport Holding AB (short name: BONEX), a small cap company…
Read More » -
Biologics
BONESUPPORT™ Founder Lars Lidgren Receives the 2017 OREF Clinical Research Kappa Delta Award
Lund, Sweden, 16 March, 2017 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone…
Read More » -
Biologics
BONESUPPORT confirms election of Dr. Håkan Björklund as Chairman of the Board
Lund, Sweden, 16 December 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone…
Read More » -
Biologics
BONESUPPORT™ Announces Key Corporate Appointment To Drive Growth in North America
Lund, Sweden, 7 November, 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone graft substitutes to treat…
Read More » -
Financial
BONESUPPORT™ Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT™ Injectable Drug Eluting Bioceramic Platform
LUND, Sweden, October 26, 2016 /PRNewswire/ — BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids…
Read More » -
Biologics
BONESUPPORT™‘s CERAMENT™|G Highly Effective Adjunct in the Single Stage Surgical Management of Chronic Osteomyelitis – Results from Prospective Study of 100 patients Published in The Bone and Joint Journal
Lund, Sweden, 1 September 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioresorbable bone graft substitute products to…
Read More » -
Hospitals
BONESUPPORT™‘s CERAMENT™|G and CERAMENT™ V to be Featured Extensively at the 35th Annual Meeting of the European Bone & Joint Infection Society (EBJIS) in Oxford, UK
Lund, Sweden, 30 August 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat…
Read More » -
Hospitals
BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study with CERAMENT™G
Lund, Sweden, 9 August – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone…
Read More » -
Biologics
BONESUPPORT™ Announces Results Of CERAMENT™|BONE VOID FILLER Prospective Pilot Study Demonstrating Complete Bone Remodeling In Benign Bone Tumors
LUND, Sweden, Dec. 10, 2015 /PRNewswire/ — BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument…
Read More » -
Recon
New Data From Oxford University Hospitals Demonstrate Superior Outcome With CERAMENT™ Antibiotic Eluting Bone Substitute Compared To Collagen And Calcium Sulfate In The Management Of Chronic Osteomyelitis
LUND, Sweden, Oct. 6, 2015 /PRNewswire/ — BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument…
Read More »